2024年度実績

2024年度業績

【英文論文】

Kazutaka Oda, Hideyuki Hayashi, Keiichi Yamamoto, Shoji Kondo, Tomomi Katanoda, Shinichiro Okamoto, Toshikazu Miyakawa, Eisaku Iwanaga, Kisato Nosaka, Tatsuya Kawaguchi, Hirotomo Nakata. Antibiotic spectrum coverage scoring as a potential metric for evaluating the antimicrobial stewardship team activity: a single-center study. Infect Control Hosp Epidemiol. 2024; 45:1-9.
 
Kazutaka Oda, Shinichiro Okamoto, Eisaku Iwanaga, Hirotomo Nakata. Investigating the WHO’s AWaRe classification for assessing antimicrobial stewardship programs: A single-center study. J Infect Chemother. 2025; 31:102511.
 
Yamamoto S, Kuriyama H, Kashiwada-Nakamura K, Kajihara I, Makino K, Aoi J, Miyashita A, Yoshida C, Kubo Y, Fukushima S. A case of unknown primary melanoma detected with BRAF gene mutation from pleural fluid cell block. J Dermatol. 2023;50:e305-e306.
 
Natsuki Takeda , Toshiyuki Koya, Takashi Hasegawa, Moe Tanaka, Takahiro Matsuda, Yui Murai, Shun Naramoto, Yosuke Kimura, Kenjiro Shima, Makoto Kurokawa, Ami Aoki, Chieko Yoshida, Takuro Sakagami, Shuichiro Maruoka, Yasuhiro Gon, Toshiaki Kikuchi; Niigata Asthma. A Prevalence and characteristics of dysfunctional breathing in patients with asthma in Japanese population. Respiratory Investigation. 2024;62:1015-1020.
 
Yuiko Masuda, Hiroko Okabayashi, Kimitaka Akaike,Shohei Hamada, Aiko Masunaga, Hidenori Ichiyasu,Kenichi Ohashi, Takuro Sakagami. Case Report: Tattoo sarcoidosis with epithelioid cell granuloma positive for Propionibacterium acnes. Front Med. 12:1552114.
 
Anai M, Inoue H, Saruwatari K, Oda S, Shiraishi S, Akaike K, Imamura K, Jodai T, Sakata S, Iyama S, Tomita Y, Ichiyasu H, Sakagami T. Negative-predictive value of SUVmax for Ascertaining the efficacy of osimertinib in EGFR mutation-positive non-small cell lung cancer. Respir Investig. 2024; 62: 1072-1078.
 
Taishi Harada, Tomonari Sasaki, Hidenobu Ishii, Shinnosuke Takemoto, Yasushi Hisamatsu, Haruhiro Saito, Yasuto Yoneshima, Kazutoshi Komiya, Kosuke Kashiwabara, Katsuhiko Naoki, Tomohiro Ogawa, Hiroaki Takeoka, Koichi Saruwatari, Kensaku Ito, Yuko Tsuchiya-Kawano, Keiko Mizuno, Takayuki Shimose, Yoshiyuki Shioyama, Isamu Okamoto. A phase II study of weekly carboplatin and concurrent radiotherapy in older adults with locally advanced non-small cell lung cancer (LOGIK1902). Thorac Cancer. 2024; 15: 2128-2135.
 
Miyazaki A, Saruwatari K, Yamanaka T, Shiraishi K, Tomita Y, Ichiyasu H, Sakagami T. Durable Response of Pembrolizmab for EGFR Mutation-positive Lung Adenocarcinoma with Early Progression to Osimertinib in First-line Treatment. Intern Med. 2025 Jan 15;64(2):267-271.
 
Yasumiko Jodai, Koichi Saruwatari, Kei Muramoto, Kosuke Imamura, Syinya Sakata, Chieko Yoshida, Yuko Miyasato, Yumi Honda, Yusuke Tomita, Hidenori Ichiyasu, Takuro Sakagami. A Case of Rapid Emergence of Small-cell Carcinoma due to Malignant Transformation or de novo Formation in the Anterior Mediastinum Following Thymoma Resection: The Importance of a Re-biopsy. Intern Med. 2024 Dec 26. doi: 10.2169/internalmedicine.4566-24. Online ahead of print.
 
Kakiuchi Y, Saruwatari K, Murotani K, Tokito T, Iriki T, Iwakawa J, Sakata Y, Shingu N, Saeki S, Inaba M, Takaki A, Misono S, Suetsugu T, Azuma K, Mizuno K, Sakagami T. Real-World Efficacy and Safety of Durvalumab Administration Following Chemoradiotherapy in Elderly Patients With Unresectable Locally Advanced Nonsmall Cell Lung Cancer: A Multicenter, Retrospective Study. Clin Lung Cancer. 2024; 25: 661-671.e7.
 
Fujimoto D, Hayashi H, Murotani K, Toi Y, Yokoyama T, Kato T, Yamaguchi T, Tanaka K, Miura S, Tamiya M, Tachihara M, Shukuya T, Tsuchiya-Kawano Y, Sato Y, Ikeda S, Sakata S, Masuda T, Takemoto S, Otsubo K, Shibaki R, Makino M, Okamoto I, Yamamoto N. Prediction of prognosis in lung cancer using machine learning with inter-institutional generalizability: A multicenter cohort study (WJOG15121L: REAL-WIND). Lung Cancer. 2024;194:107896.
 
Shibaki R, Fujimoto D, Miyauchi E, Tsukita Y, Nakachi I, Arai D, Sakata Y, Shingu N, Shimokawa T, Kijima T, Tamiya M, Kawana S, Hara S, Saito G, Sato Y, Yokoyama T, Sakata S, Taniguchi Y, Hata A, Matsumoto H, Yamaguchi T, Yamamoto N. Durvalumab with etoposide and carboplatin for patients with extensive-stage small cell lung cancer and interstitial lung disease: A multicenter, open-label prospective trial. Lung Cancer. 2024;196:107958
 
Sugisaka J, Fujimoto D, Tamiya M, Hata A, Matsumoto H, Yokoyama T, Taniguchi Y, Uchida J, Sato Y, Kijima T, Tanaka H, Furuya N, Masuda T, Sakata Y, Miyauchi E, Saito G, Miura S, Yamaguchi T, Daga H, Sakata S, Yamamoto N, Akamatsu H. Long-term outcome of chemoimmunotherapy for extensive-stage small-cell lung cancer according to key clinical trial eligibility: 3-year outcomes from a prospective cohort study. Lung Cancer. 2025;199:108056.
 
Fujimoto D, Shibaki R, Kimura K, Haratani K, Tamiya M, Kijima T, Sato Y, Hata A, Yokoyama T, Taniguchi Y, Uchida J, Tanaka H, Furuya N, Miura S, Onishi MI, Sakata S, Miyauchi E, Yamamoto N, Koh Y, Akamatsu H. Identification of key gene signatures for predicting chemo-immunotherapy efficacy in extensive-stage small-cell lung cancer using machine learning. Lung Cancer. 2025;199:108079
 
Akamatsu H, Sakata S, Azuma K, Yoshioka H, Uemura T, Tsuchiya-Kawano Y, Esumi S, Kurosaki T, Sato Y, Sakamoto T, Ninomiya K, Toyozawa R, Yoneshima Y, Shukuya T, Kozuki T, Watanabe K, Daga H, Kato T, Takahashi T, Osuga M, Koh Y, Morita S, Yamamoto N. A single-arm, phase II study of sotorasib plus carboplatin/pemetrexed in advanced non-squamous non-small cell lung cancer patients with KRAS G12C mutation (WJOG14821L, SCARLET). J Thorac Oncol. 2025.in press. doi:10.1016/j.jtho.2025.01.006
 
Hotta K, Saeki S, Sakata S, Yamaguchi M, Harada D, Bessho A, Tanaka K, Inoue K, Inoue K, Gemba K, Kubo T, Sato A, Ichihara E, Watanabe H, Kishimoto J, Shioyama Y, Katsui K, Sugio K, Kiura K. Five-year outcomes with gefitinib induction and chemoradiotherapy in EGFR-mutant stage III non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II study. Int J Clin Oncol. 2025 in press. Doi: 10.1007/s10147-025-02696-3.
 
Kimitaka Akaike, Koichi Saruwatari, Shinya Sakata, Seitaro Oda, Shinya Shiraishi, Shinji Iyama, Aiko Masunaga, Yusuke Tomita, Hidenori Ichiyasu, Takuro Sakagami. 18F-FDG accumulation at the early onset of acute exacerbation of idiopathic interstitial pneumonia on (18)F-FDG PET/CT: A case report. Respirol Case Rep. 2024 Jul 14;12(7):e01427.
 
Arai T, Inoue Y, Akasaka K, Masunaga A, Fujita M, Yamaguchi E, Saigusa M, Murakami K, Kurahara Y, Tsuyuguchi K, Suzuki T, Miyazaki Y, Bando M, Suda T. Severity and prognosis of COVID-19 complicated by autoimmune pulmonary alveolar proteinosis. Respiratory Investigation. 2025;63(1):20–26
 
Zhu L., Gao E., Tomita Y., Li A., Tao B. Circulating tumor cells are associated with lung cancer subtypes: a large-scale retrospective study. Transl Lung Cancer Res. 2024;13:3122-3138.
 
Jodai Y, Saruwatari K, Muramoto K, Imamura K, Sakata S, Yoshida C, Miyasato Y, Honda Y, Tomita Y, Ichiyasu H, Sakagami T.　A Case of Rapid Emergence of Small-cell Carcinoma due to Malignant Transformation or de novo Formation in the Anterior Mediastinum Following Thymoma Resection: The Importance of a Re-biopsy. Intern Med. 2024 Dec 26. doi: 10.2169/internalmedicine.4566-24. Online ahead of print.
 
Anai M, Hamada S, Jodai T, Okabayashi H, Saruwatari K, Tomita Y, Ichiyasu H, Sakagami T. Pulmonary Tumor Embolism due to Oropharyngeal Carcinoma Diagnosed by a Transbronchial Lung Biopsy. Intern Med. 2025 Jan 15;64(2):267-271.
 
Okabayashi H, Nakashima S, Fujino K, Imai M, Hamada S, Masunaga A, Ichiyasu H, Suzuki M, Sakagami T. Tension Pneumomediastinum in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung Disease: A Case Report and Literature Review. Intern Med. 2024 Dec 1;63(23):3221-3226.
 
Sakagami T. Advancements in pulmonary alveolar proteinosis treatment: A journey from discovery to GM-CSF inhalation therapy. Respir Investig. 2024 May;62(3):375-376.
 
Imai M, Okabayashi H, Akaike K, Hamada S, Masunaga A, Ichiyasu H, Sakagami T. Comparison of nintedanib-induced gastrointestinal adverse events between patients with systemic sclerosis-associated interstitial lung disease and idiopathic interstitial pneumonias. Respir Investig. 2024 May;62(3):317-321.